Patrick Mooney is the founder of Linnaeus Therapeutics. Linnaeus Therapeutics has raised $72M in total funding. Latest round: Series B.
Patrick Mooney is the CEO of Linnaeus Therapeutics, a clinical-stage biopharmaceutical company focused on developing small-molecule oncology therapeutics. He has guided the company through multiple funding rounds, including federal grants from the National Cancer Institute and ARPA-H.
Full founder directory · Investor directory · Company funding database · Fundraising library